EP0304461A1 - Technique amelioree d'analyse et appareil prevu a cet effet - Google Patents

Technique amelioree d'analyse et appareil prevu a cet effet

Info

Publication number
EP0304461A1
EP0304461A1 EP88902172A EP88902172A EP0304461A1 EP 0304461 A1 EP0304461 A1 EP 0304461A1 EP 88902172 A EP88902172 A EP 88902172A EP 88902172 A EP88902172 A EP 88902172A EP 0304461 A1 EP0304461 A1 EP 0304461A1
Authority
EP
European Patent Office
Prior art keywords
optical structure
sample
specific binding
ligand
binding partner
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP88902172A
Other languages
German (de)
English (en)
Inventor
Craig George Sawyers
Rosemary Ann Lucy Drake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ares Serono Research and Development LP
Original Assignee
Ares Serono Research and Development LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Serono Research and Development LP filed Critical Ares Serono Research and Development LP
Publication of EP0304461A1 publication Critical patent/EP0304461A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/645—Specially adapted constructive features of fluorimeters
    • G01N21/648—Specially adapted constructive features of fluorimeters using evanescent coupling or surface plasmon coupling for the excitation of fluorescence
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/55—Specular reflectivity
    • G01N21/552—Attenuated total reflection
    • G01N21/553—Attenuated total reflection and using surface plasmons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
    • G01N21/7703—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator using reagent-clad optical fibres or optical waveguides
    • G01N21/774—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator using reagent-clad optical fibres or optical waveguides the reagent being on a grating or periodic structure
    • G01N21/7743—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator using reagent-clad optical fibres or optical waveguides the reagent being on a grating or periodic structure the reagent-coated grating coupling light in or out of the waveguide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553—Metal or metal coated

Definitions

  • This invention concerns assay techniques by which qualitative and/or quantitative detection of chemical, biochemical or biological analytes in a sample can be determined and also concerns apparatus by which such techniques can be performed.
  • Assay techniques referred to are based on the affinity between the analyte which is to be assayed and a receptive material for example a ligand or a specific binding partner, which is coated onto a particular type of surface.
  • a receptive material for example a ligand or a specific binding partner, which is coated onto a particular type of surface.
  • Reference is made to International Patent Publications WO84/02578 and O86/01901 for descriptions of assay techniques comprising (a) coating at least a predetermined part of a surface having a preformed relief profile on a substrate with a thin film of a material capable of binding the species to be assayed, the surface part being optically active with respect to radiation at least over a predetermined band of wavelengths, and (b) contacting the coated surface with the sample and observing the optical properties of the surface part in order to determine a qualitative and/or quantitative change in optical properties as a result of the binding of the species onto the thin film of material on the surface.
  • the preformed relief profile is typically in the form of an optical grating which may be a simple single grating of two or more crossed gratings the ridges of which may have square, sinusoidal or triangular cross-sectional shape, and as employed herein, references to a grating are intended to encompass all such gratings.
  • publication WO84/02578 the change in optical properties of the grating as a result of the binding of an analyte to be assayed (such as a specific antigen in a blood serum) is brought about essentially as a result of (1) the mass or bulk of the bound analyte and (2) its dielectric properties.
  • the binding events are monitored by changes in the fluorescent properties of a dye-tagged binding partner attached to the sensoc surface.
  • the grating surface is essentially opaque, at least at the. wavelength of the radiation used for illumination, and the grating can therefore be considered to be a reflective diffraction grating.
  • Changes in the properties of the grating which occur as a result of the deposition thereon of analytes or other material as a result of the assay technique appear as changes in the reflective characteristics of the grating (for WO84/02578) and fluorescent emission characteristics (WO86/01901) in the manner described in the a orementioned speci ications.
  • the invention provides a method of assaying for a ligand in a sample which comprises incubating the sample in contact with one surface of an optical structure capable of exhibiting surface plasmon resonance, the said surface having adsorbed thereon or bound thereto, either directly or indirectly, a specific binding partner for the ligand it is desired to detect; irradiating the other surface of the optical structure with radiation of an appropriate wavelength; and analysing the reflected radiation in order to determine whether, and if desired the extent to which and/or rate at which, the surface plasmon resonance characteristics of the optical structure are altered by formation of a complex between the ligand and the specific binding partner .
  • the optical structure is a diffraction grating of a clear plastics or glass material and the grating is coated with a thin metal or metal-like layer which is partially reflective and partially transmissive, at least at the wavelength of radiation which is to be used to illuminate and observe the grating for investigative purposes.
  • the ligand to be assayed for will be an antibody or an antigen and the specific binding partner will then be the complementary antigen or antibody.
  • the invention further provides an apparatus for detecting one or more ligands in a sample which apparatus comprises a reservoir for holding the sample to be tested, at least part of an internal surface of said reservoir comprising an optical structure capable of exhibiting surface plasmon resonance, that surface of the said structure which in use will contact the sample having adsorbed thereon or bound thereto, either directly or indirectly, a specific binding partner for the ligand it is desired to detect.
  • One embodiment of the apparatus of the invention further comprises means for irradiating from outside the reservoir that surface of the optical structure which in use will be remote from the sample; and means for analysing the reflected radiation in order to determine whether, and if desired the extent to which and/or rate at which, the surface plasmon resonance characteristics of the said optical structure are altered by formation of a complex between the ligand and the specific binding partner.
  • the reservoir comprises a shallow well having a flat bottom having a diffraction grating formed on its upper face within the well and a partially reflecting, partially transmitting thin metal or metal ⁇ like film applied to the grating surface.
  • the metal film is preferably coated by a further film of an inert material which, whilst enabling the diffraction grating to exhibit surface plasmon resonance when activated by appropriate wavelength light, nevertheless prevents chemical interaction between the metal and the rea ⁇ tants within the reservoir.
  • a further advantage is that reactions can be monitored as they occur and therefore the end point of the assay can be predicted, thereby reducing the length of time taken to perform the assay.
  • An additional advantage is that no separation of the sample from the sensor is needed before measurement.
  • the invention is thus suitable for use with whole blood samples and other biological samples containing light scattering compounds or particulate material .
  • the invention also enables a competition assay to be performed in the wet or dry where a reagent antigen is fluorophor-labelled, or a sandwich assay to be performed in which a second antibody is fluorophor-labelled.
  • the use of fluorophor-labelled material is possible provided the detection means is capable of discriminating between different wavelengths of light received thereby and in particular determining whether or not light of a wavelength corresponding to that produced by the fluorophor label is present in the light re-radiated from the grating.
  • a monochromatic or quasi- monochromatic light source is used as the primary source for illuminating the grating and typically a laser is used for this purpose, although it will be understood that this by no means restricts the choice of light source to a laser, and the angle of incidence of the light is altered.
  • a polychromatic e.g. white light source may be used, the angle of incidence held constant and the wavelength characteristics of the reflected light analysed in order to detect surface plasmon resonance effects.
  • Figure 2 illustrates diagra matically apparatus by which an assay may be performed in accordance with the invention and which itself embodies the preferred constructional features of the invention.
  • Figure 1 shows the results obtained from an injection moulded diffraction grating which was coated with 50 nm of silver by vacuum evaporation and interrogated from the underside of the grating with a helium-neon laser
  • a shallow well 10 "" is formed in a clear plastics material having a flat base 12 on the upper internal face of which is formed a diffraction grating 14 by any appropriate proc €ss such as impression moulding or machining or otherwise.
  • the upper surface of the grating 14 is coated with a semi-reflective metal or metal-like film for example silver or aluminium or copper or gold, and if an intermediate inert layer is required between the metallic film and the reagents to be placed in the well, the surface is itself coated with a layer of an appropriate buffer material such as an oxide of silicon.
  • the grating is coated with a thin film of material comprising specific antigens, antibodies or other binding partners which may be tagged with a fluoroescent compound and the well is now ready to receive a liquid containing the specific antibody or antigen or complementary binding partners to be tested.
  • the article containing the well is inserted into apparatus shown diagrammatically at 16 which contains a laser light source 18, light from which is projected, using suitable optical means (not shown), to impinge on the underside of the well at an appropriate angle of incidence to set up surface plasmon resonance in the diffraction grating.
  • a wavelength sensitive light detector 20 is also located within the housing 16 and the output from the detector 20 is supplied to electrical processing and display apparatus such as 22 which may or may not be included within the housing.
  • Adjustments are made to the detector 20 and processing and display circuits 22 to produce a first reading when the well is illuminated in position and contains a non-ligand containing liquid.
  • a sample which may or may not contain a ligand is then added to the well in any convenient manner and the output of the detector 20 as displayed by the apparatus 22 is monitore to determine any change.
  • the detector can be set to determine whether or not any light of the wavelength of the fluorescent label in the assay can be detected.
  • the light source 18 may of course be used to illuminate a plurality of wells simultaneously and either a corresponding plurality of detectors may be employed or a detector set to scan each well in succession may be employed so that an assa of a large number of different samples can be carried out relatively quickly.
  • a number of defined regions on the surface of a single well can each have a different binding partner thereon and these can be employed either to measure number of different analytes simultaneously, or to provide a measure of the non-specific binding, by comparison with "control" regions, which may carry for example a binding partner which is not itself specific for any ligand which ma be present in the sample to be tested.

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Optics & Photonics (AREA)
  • Inorganic Chemistry (AREA)
  • Plasma & Fusion (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Un procédé d'analyse pour détecter un ligand, dans un échantillon, qui comprend l'incubation de l'échantillon en contact avec une surface d'une structure optique susceptible de présenter une résonance du plasmon en surface, ladite surface sur laquelle est adsorbé ou à laquelle est lié, directement ou indirectement, un coélément de liaison spécifique du ligand que l'on souhaite détecter. Ce procédé comprend l'irradiation de l'autre surface de la structure optique avec un rayonnememt d'une longueur d'onde appropriée, et l'analyse du rayonnement réfléchi afin de déterminer si, et le cas échéant, dans quelle mesure et/ou à quel degré les caractéristiques de la résonance du plasmon en surface de la structure optique sont modifiées par formation d'un complexe entre le ligand et le coélément de liaison spécifique. Un appareil permettant de détecter un ou plusieurs ligands, dans un échantillon qui convient à l'utilisation dans le procédé de l'invention, est également présenté.
EP88902172A 1987-03-10 1988-03-09 Technique amelioree d'analyse et appareil prevu a cet effet Withdrawn EP0304461A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878705650A GB8705650D0 (en) 1987-03-10 1987-03-10 Assay technique
GB8705650 1987-03-10

Publications (1)

Publication Number Publication Date
EP0304461A1 true EP0304461A1 (fr) 1989-03-01

Family

ID=10613686

Family Applications (1)

Application Number Title Priority Date Filing Date
EP88902172A Withdrawn EP0304461A1 (fr) 1987-03-10 1988-03-09 Technique amelioree d'analyse et appareil prevu a cet effet

Country Status (5)

Country Link
EP (1) EP0304461A1 (fr)
JP (1) JPH01502930A (fr)
AU (1) AU1391288A (fr)
GB (1) GB8705650D0 (fr)
WO (1) WO1988007202A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1321488C (fr) 1987-08-22 1993-08-24 Martin Francis Finlan Detecteurs biologiques
GB8801807D0 (en) * 1988-01-27 1988-02-24 Amersham Int Plc Biological sensors
GB8817710D0 (en) * 1988-07-25 1988-09-01 Ares Serono Res & Dev Ltd Method of assay
US5478755A (en) * 1988-07-25 1995-12-26 Ares Serono Research & Development Ltd. Long range surface plasma resonance immunoassay
GB8924951D0 (en) * 1989-11-04 1989-12-28 Fisons Plc Device and methods
EP0515370B1 (fr) * 1990-02-22 1995-03-01 THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING (McGILL UNIVERSITY) Systeme d'immunoanalyse interferometrique a phase solide
NL9001052A (nl) * 1990-05-02 1991-12-02 Tno Werkwijze voor het bepalen van een specifiek ligand in een vloeibaar monster met behulp van een evanescent veld, alsook een daarvoor geschikt onderdeel van de benodigde meetinrichting.
DE69110032T2 (de) * 1991-06-08 1995-12-21 Hewlett Packard Gmbh Verfahren und Gerät zur Feststellung und/oder Konzentrationsbestimmung von Biomolekülen.
GB9120000D0 (en) * 1991-09-19 1991-11-06 British Gas Plc Optical sensing
US5846843A (en) * 1996-11-18 1998-12-08 The University Of Toledo Sensor using long range surface plasmon resonance with diffraction double-grating
US5776785A (en) * 1996-12-30 1998-07-07 Diagnostic Products Corporation Method and apparatus for immunoassay using fluorescent induced surface plasma emission
DE19715483A1 (de) * 1997-04-14 1998-10-15 Boehringer Mannheim Gmbh Methode zur gleichzeitigen Bestimmung von biomolekularen Wechselwirkungen mittels Plasmonenresonanz undFluoreszenzdetektion
DE19903576C2 (de) * 1999-01-29 2001-02-22 Bodenseewerk Perkin Elmer Co Quantitative Bestimmung von Analyten in einem heterogenen System
JP2003533692A (ja) * 2000-05-06 2003-11-11 ツェプトゼンス アクチエンゲゼルシャフト 多重分析対象物測定及びその使用のための格子導波路構造
DE10064146A1 (de) * 2000-12-22 2002-07-04 Andreas Hofmann Biosensor und verfahren zu seiner Herstellung
US7807348B2 (en) * 2002-03-20 2010-10-05 Wisconsin Alumni Research Foundation Optical imaging of nanostructured substrates
DE102004027957A1 (de) * 2004-06-08 2005-12-29 Carl Zeiss Jena Gmbh Verfahren und Anordnung zur Untersuchung der Wechselwirkung von Biomolekülen
GB2431233A (en) * 2005-10-14 2007-04-18 E2V Tech Molecular detector arrangement
PT103601B (pt) * 2006-11-09 2008-10-14 Biosurfit Sa Dispositivo de detecção baseado no efeito de ressonância de plasmão de superfície
DE202007014923U1 (de) * 2007-10-24 2009-02-26 Bioscitec Gmbh Wannenförmiges Behältnis für optisch zu analysierende Testobjekte und Herstellungsvorrichtung dafür
JP2011226925A (ja) * 2010-04-20 2011-11-10 National Institute Of Advanced Industrial & Technology 周期構造を有するマイクロプレート及びその製造方法
JP5622215B2 (ja) * 2013-10-29 2014-11-12 独立行政法人産業技術総合研究所 周期構造を有するマイクロプレート、並びに、それを用いた表面プラズモン励起増強蛍光顕微鏡、蛍光マイクロプレートリーダーおよび特異的な抗原抗体反応の検出方法
WO2015155799A1 (fr) * 2014-04-08 2015-10-15 コニカミノルタ株式会社 Dispositif et procédé de mesure de fluorescence améliorée par plasmons de surface

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3979184A (en) * 1975-05-27 1976-09-07 General Electric Company Diagnostic device for visually detecting presence of biological particles
DE3135196A1 (de) * 1981-09-05 1983-03-17 Merck Patent Gmbh, 6100 Darmstadt Verfahren, mittel und vorrichtung zur bestimmung biologischer komponenten
CA1237645A (fr) * 1982-12-21 1988-06-07 John H. Fisher Technique analytique
AU588245B2 (en) * 1984-06-13 1989-09-14 Inverness Medical Switzerland Gmbh Devices for use in chemical test procedures
US4647544A (en) * 1984-06-25 1987-03-03 Nicoli David F Immunoassay using optical interference detection
GB8423204D0 (en) * 1984-09-14 1984-10-17 Comtech Res Unit Assay technique and equipment
GB8618133D0 (en) * 1986-07-24 1986-09-03 Pa Consulting Services Biosensors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO8807202A1 *

Also Published As

Publication number Publication date
WO1988007202A1 (fr) 1988-09-22
AU1391288A (en) 1988-10-10
JPH01502930A (ja) 1989-10-05
GB8705650D0 (en) 1987-04-15

Similar Documents

Publication Publication Date Title
EP0304461A1 (fr) Technique amelioree d'analyse et appareil prevu a cet effet
EP0167335B1 (fr) Méthode de détection d'une réaction de liaison entre un ligand et un antiligand
US5132097A (en) Apparatus for analysis of specific binding complexes
US5350697A (en) Scattered light detection apparatus
USRE33581E (en) Immunoassay using optical interference detection
CN102033054B (zh) 对基于衍射的诊断的结果进行观察和分析的方法
US7193711B2 (en) Imaging method and apparatus
US20110111487A1 (en) Mehtod and apparatus for assay based on light diffraction
JPH0627703B2 (ja) 物質の選択的検出および測定物質内の屈折率変化検知を行なう光学センサ
WO1994012882A1 (fr) Dosage de ligand par modulation d'interference
CA2521773C (fr) Dispositif optique de detection chimique a transducteur pyroelectrique ou piezo-electrique
US20160161406A1 (en) Cartridge for analyzing specimen by means of local surface plasmon resonance and method using same
EP1021708A1 (fr) Utilisation de biocapteurs pour diagnostiquer des maladies des plantes
US20030104390A1 (en) Use of biosensors to diagnose plant diseases
US20040047770A1 (en) Cuvette for a reader device for assaying substances using the evanescence field method
JP5356219B2 (ja) 化学的検知装置
WO1993025910A1 (fr) Dosage de plusieurs analytes a l'aide de ligands co-immobilises
EP1390719A1 (fr) Appareil et procede d'imagerie
WO1994000763A1 (fr) Procede de determination d'immunocomplexes multiples sur une surfface par spectroscopie
JP2005077396A (ja) 分析用光導波路
JP2007292598A (ja) 標的物質検出用の素子及びそれを作製するための基体、ならびにそれを用いた標的物質の検出方法及び検出装置
NO884985L (no) Forbedret evalueringsteknikk og apparat for utoevelse av denne.
AU3145393A (en) Ligand assay using interference modulation
Hartman Optical Biosensors for Microbiological Analysis
US20090081694A1 (en) Modified well plates for molecular binding studies

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19881028

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17Q First examination report despatched

Effective date: 19900831

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19910312

R18W Application withdrawn (corrected)

Effective date: 19910312